Mohammad Feroz Alam Editor

Adil Denizli is Professor at Hacettepe University, Department of Chemistry, Ankara, Turkey. His main research fields are molecular imprinting technologies, purification of biomolecules by chromatographic methods, detection of molecules by sensors, production of polymers with different surface and bulk properties, shape and geometries, and application of these polymers in different applications. Dr. Tuan Anh Nguyen is a Principal Research Scientist at the Institute for Tropical Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam. He received his BSc in Physics from Hanoi University in 1992 and his Ph.D. in Chemistry from the Paris Diderot University (France) in 2003. He was a Visiting Scientist at Seoul National University (South Korea, 2004) and University of Wollongong (Australia, 2005). He then worked as a Postdoctoral Research Associate and Research Scientist at the Montana State University (USA, 2006-2009). His research interests include smart coatings, conducting polymers, corrosion and protection of metals/concrete, antibacterial materials, and advanced nanomaterials. Mariappan Rajan is currently working as an Assistant Professor in the Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, India. He is an experienced researcher and is mainly interested in the development of biodegradable polymeric nanocarrier systems, nanogels, nanoparticles, nanocomposite scaffolds, bio-ceramic materials and mineral substituted scaffold for Tissue engineering, Drug Delivery and Wound Dressing applications. Mohammad Feroz Alam M.D (Pathology) is an Assistant Professor at J.N Medical College, AMU. He has an experience of nearly 16 years in Teaching and Research work.His areas of interest are Hematology, Histopathology, Cancer research and Nanomedicine Khaliqur Rahman is an Associate Professor in the Hematology Laboratory at Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India. His areas of research are molecular diagnostic of hematolymphoid neoplasm and advancement in flow cytometric immunophenotyping and minimal residual disease evaluation.